Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: A phase II multicenter trial

  • Gregory A. Wiseman
  • , Leo I. Gordon
  • , Pratik S. Multani
  • , Thomas E. Witzig
  • , Stewart Spies
  • , Nancy L. Bartlett
  • , Russell J. Schilder
  • , James L. Murray
  • , Mansoor Saleh
  • , Roberta S. Allen
  • , Antonio J. Grillo-López
  • , Christine A. White

Research output: Contribution to journal › Article › peer-review

283 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: A phase II multicenter trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science